Literature DB >> 9693957

Psoriasin (S100A7).

P H Watson1, E R Leygue, L C Murphy.   

Abstract

Psoriasin (S100A7) is a relatively new member of the S100 gene family that is located within the S100 gene cluster on chromosome 1q21 and shares the typical calcium binding domains that define this family of proteins. It was first identified as a 11.4 kDa cytoplasmic and secreted protein isolated from skin involved by psoriasis, which can be induced in cultured squamous epithelial cells. It is now known to be expressed by both normal cultured and malignant keratinocytes and malignant breast epithelial cells within ductal carcinoma in situ, suggesting an association with abnormal pathways of differentiation. Current evidence supports a role in the pathogenesis of inflammatory skin disease, as a chemotactic factor for hematopoietic cells, and a role in early stages of breast tumor progression in association with the development of the invasive phenotype. While therapeutic potential as a target for modulation of the inflammatory response in psoriasis awaits further studies, potential clinical applications already include a role as a detection marker for squamous cell carcinoma and a diagnostic marker to distinguish in situ from invasive breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693957     DOI: 10.1016/s1357-2725(97)00066-6

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  32 in total

1.  Psoriasin (S100A7) expression and invasive breast cancer.

Authors:  S Al-Haddad; Z Zhang; E Leygue; L Snell; A Huang; Y Niu; T Hiller-Hitchcock; K Hole; L C Murphy; P H Watson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Expression and clinical significance of S100A2 and p63 in esophageal carcinoma.

Authors:  Li-Yu Cao; Yu Yin; Hao Li; Yan Jiang; Hong-Fu Zhang
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

3.  Expression of calcium-binding proteins S100A2 and S100A4 in Barrett's adenocarcinomas.

Authors:  Ok-Jae Lee; Seung-Mo Hong; Mohammad H Razvi; Dunfa Peng; Steven M Powell; Mark Smoklin; Christopher A Moskaluk; Wael El-Rifai
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

4.  Knockdown of S100A7 reduces lung squamous cell carcinoma cell growth in vitro and in vivo.

Authors:  Guijuan Liu; Qiang Wu; Guilan Liu; Xueying Song; Jihong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

5.  Solution structure and backbone dynamics of human epidermal-type fatty acid-binding protein (E-FABP).

Authors:  Luis H Gutiérrez-González; Christian Ludwig; Carsten Hohoff; Martin Rademacher; Thorsten Hanhoff; Heinz Rüterjans; Friedrich Spener; Christian Lücke
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

Review 6.  Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease.

Authors:  Anne M Fagan; Richard J Perrin
Journal:  Biomark Med       Date:  2012-08       Impact factor: 2.851

7.  Differential expression of S100 gene family in human esophageal squamous cell carcinoma.

Authors:  Junfang Ji; Liqun Zhao; Xiuqin Wang; Chuannong Zhou; Fang Ding; Lei Su; Chunlin Zhang; Xuezheng Mao; Min Wu; Zhihua Liu
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-04       Impact factor: 4.553

8.  Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation.

Authors:  Yan Zheng; François Niyonsaba; Hiroko Ushio; Shigaku Ikeda; Isao Nagaoka; Ko Okumura; Hideoki Ogawa
Journal:  Immunology       Date:  2008-01-08       Impact factor: 7.397

9.  S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10.

Authors:  Weiping Qin; Lap Ho; Jun Wang; Elaine Peskind; Giulio Maria Pasinetti
Journal:  PLoS One       Date:  2009-01-13       Impact factor: 3.240

10.  Current concepts in the pathogenesis of psoriasis.

Authors:  Rajeev Patrick Das; Arun Kumar Jain; V Ramesh
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.